Preclinical testing at The Ohio State University found Telomir-Zn inhibited growth of canine and human osteosarcoma cell lines, prompting the company to explore a possible in-vivo study in dogs with naturally occurring tumors.
|Articles|March 15, 2010
Veterinary regenerative medicine group started
Davis, Calif. -- The new North American Veterinary Regenerative Medicine Association wants to recruit medicine researchers, stem cell biologists, and others with an interest in stem cell therapy.
Advertisement
Davis, Calif. -
The new North American Veterinary Regenerative Medicine Association wants to recruit medicine researchers, stem cell biologists, and others with an interest in stem cell therapy.
Advertisement
The association was formed at the inaugural North American Veterinary Regenerative Medicine Conference March 5 to 6 at University of California Davis' Center for Equine Health, which drew 280 research scientists, veterinarians and physicians.
“[Our] goal is to facilitate scientific investigations with stem cells that are acquired from fat, bone-marrow and umbilical-cord sources, and to combine that knowledge with other regenerative medicine techniques that are designed to improve the health care of animals and humans alike,” says Sean Owens, a veterinary professor and director of UC Davis’ Regenerative Medicine Laboratory.
Membership information is available from Owens ([email protected]) or UC Davis Center for Equine Health director Gregory Ferraro ([email protected]).
Advertisement
Related to this article
Caroline Cox, LSW, MSW, and Erika Krick, VMD, DACVIM (Oncology), discuss the role of veterinary social workers in supporting clients, communicating with veterinary teams, and helping practices address the human side of veterinary care in this Q&A from an interview at the 2026 Fetch National Harbor Veterinary Conference.
After more than 20 years of work toward its first rhino birth, the Texas ranch has now welcomed 3 calves in 3 years.
Two notable pet-industry acquisitions closed in September. One bringing AI-powered clinical documentation into IDEXX's software ecosystem, the other marking the first acquisition for fresh-food brand The Farmer's Dog.
New leadership moves, recognition, and achievement.
In a keynote address at the 2026 Fetch National Harbor Veterinary Conference, Jessica Pritchard, VMD, MS, DACVIM (SAIM), shared research showing that many owners decline vaccines because they do not think their pet needs them, and discussed ways veterinary teams can address those concerns.
Alyssa Mages, BS, CVT, FVTE, outlines key considerations for veterinary technicians during triage, from rapid patient assessment and prioritization to client communication and team coordination, in this interview from the 2026 Fetch National Harbor Veterinary Conference.
In a session at the 2026 Fetch National Harbor Veterinary Conference, Nathanael Oster, VMD, MBA, walked attendees through the biology, diagnosis, and treatment of the flea tapeworm in dogs and cats, including why cats are affected more often than dogs.
Advertisement
Advertisement
Trending on dvm360
1
Why pet owners decline vaccines: Survey insights and strategies for navigating hesitancy
2
Recent acquisitions: IDEXX buys CoVet, The Farmer's Dog acquires Woof
3
Paws and profits: Schwarzman AMC names zoological department head, Mars names chief digital and information officer, and more updates
4
Good flea control is good tapeworm control, veterinarian tells Fetch attendees
5